Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,043.48 +25.09 (+0.50%) Dow
38,097.44 +194.15 (+0.51%) Nasdaq
15,755.12 +149.63 (+0.96%) Bitcoin USD
59,225.33 +2,434.41 (+4.29%) CMC Crypto 200
1,278.31 +7.57 (+0.60%)
scPharmaceuticals Inc. (2SX.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 04:01PM CEST. Market open.
| Previous close | 4.2000 |
| Open | 4.2000 |
| Bid | 4.2200 x 0 |
| Ask | 4.3400 x 0 |
| Day's range | 4.1400 - 4.2000 |
| 52-week range | 4.0000 - 11.2000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 151.937M |
| Beta (5Y monthly) | 0.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
scPharmaceuticals Inc. ( NASDAQ:SCPH ) shareholders might be concerned after seeing the share price drop 23% in the...
- Insider Monkey
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48. SCPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to scPharmaceuticals Fourth Quarter and […]
- GuruFocus.com
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
Sequential Revenue Growth and R&D Advancements Mark Year-End Highlights
© 2024 Yahoo. All rights reserved.